Tsung Mou
Urogynecology and Reconstructive Pelvic Surgery · Boston, MANPI 1235524752
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (41.0%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. 13 manufacturers reported payments, led by Intuitive Surgical at 54.8% of the total. Reporting peaked in 2023 at $7,021 and has fallen 97.5% since, to $175 in 2025.
Across 53 payments — averaging $184.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$5K
- Axonics, Inc.$3K
- Boston Scientific$650
- AbbVie$224
- Medtronic$181
- Coloplast$118
- plus $296 from 7 others
What the payments were for
- Speaking & faculty fees$4,00041%
- Travel & lodging$2,35724%
- Food & beverage$2,33324%
- Education$1,07011%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 6 | $5,350 |
| Axonics, Inc. | 20 | $2,940 |
| Boston Scientific | 8 | $650 |
| AbbVie | 5 | $224 |
| Medtronic(2 entities) | 3 | $181 |
| Coloplast | 1 | $118 |
| Astellas Pharma US Inc | 2 | $88 |
| Applied Medical Resources Corporation | 2 | $55 |
| Convatec Inc. | 1 | $44 |
| Hologic Sales And Service, LLC | 2 | $42 |
| Minerva Surgical, Inc | 1 | $26 |
| Baxter Healthcare | 1 | $25 |
| Merck | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$9,760 in reported general payments places this provider in the 70th percentile of 35 urogynecology and reconstructive pelvic surgery providers in Massachusetts.
See all urogynecology and reconstructive pelvic surgery providers in Massachusetts →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| GemtesaVibegron | 24 | $26,391 |
| Estradiol | 56 | $3,503 |
| Clobetasol Propionate | 19 | $532 |
| Ibuprofen | 33 | $161 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 11 | $118 |
| Tramadol Hcl | 34 | $46 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 20 | $38 |
Paid to pharmacies, not to this prescriber.
Other urogynecology and reconstructive pelvic surgery in Boston
- Lori JonesBoston$22K
- John Al JamalBoston$15K
- Youngwu KimBoston$14K
- Evelyn HallBoston$6K
- Roger LefevreBoston$5K
- May WakamatsuBoston$4K
- Milena WeinsteinBoston$4K
- Edward KimBoston$3K
- Mallika AnandBoston$443
- Gnankang NapoeBoston$28
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.